Skip to content

About

MorbiMap: prescribing without a disease diagnosis — direct intervention ranking from a health state-representation map for the multimorbidity challenge. Companion to SteeraMed-RootMap. Paper: preprint forthcoming.

Topics

Resources

Stars

0 stars

Watchers

0 watching

Forks

Latest commit

 

History

14 Commits

Folders and files

NameName
Last commit message
Last commit date
 
 
 
 
 
 

Repository files navigation

MorbiMap: Prescribing Without a Disease Diagnosis?

MorbiMap:不依赖疾病诊断的处方排序?

Direct Intervention Ranking from a Health State-Representation Map for the Multimorbidity Challenge 从健康状态表征地图直接排序候选干预·面向多病共存挑战

DeepoMe License: MIT Paper ResearchGate


English | 中文


Can a health state-representation map rank candidate drugs — without a disease label?

MorbiMap is a candidate-ranking component of SteeraMed. It connects a health state-representation map — the module-weighted representation of a molecular profile — with frozen drug–module relevance tables and uses a fixed scoring program to rank candidate drugs — without requiring a disease label as input to the scoring function.

Study design at a glance

Study Design

Four DNA-methylation cohorts and two disease-associated gene signatures → module weights → frozen drug–module tables → fixed scoring → three-level evaluation.

Can one list cover two disease-label sets?

Dual-Label Coverage

Synthetic paired-profile analyses test whether a single top-20 list can recover drugs from two disease-label sets. Depression–Parkinson's mixtures retained both baselines on average; the depression-only endpoint already attained dual coverage.

Key findings

  • A hypertension gene signature recovered 6–7 antihypertensives in the top 20; removing 30 direct-target genes retained 6
  • Depression and Parkinson's high recovery was shared with healthy controls — detected by a healthy-reference differential, not by drug-only or permutation checks
  • 32% of depression–Parkinson's pairings met both baselines; the depression-only endpoint also met both
  • A degree- and weight-preserving graph null reproduced the overlap–coverage association (ρ_null = 0.85 vs observed 0.90)

Repository status

Version 1 (preprint). This repository provides the result-to-artifact index, representative figures, and version declaration. The analysis code, frozen candidate pools, positive-set files, drug–module tables, audit trail, and reproduction scripts will be released in version 2 (v2).

Result-to-artifact index

Headline result Frozen artifact (v2)
Candidate pool and sealed positive sets results/pool200_clinical_v2.json
Per-participant 72-module |ES| profiles results/_repr_gsea_signed_v2.npy + item_map_v2.json
Grounded drug–module tables (9 batches) results/geneanchor72_claude_batch*.json
Depression and PD healthy-control differential gates results/e2_triangle_full.json
Cross-fitted calibration results/e15_calibration.json + e15_calibration_seed7.json
Per-drug differential audit results/e15_diff_audit.json
HTN direct-target deletion, class deletion, null results/e16_htn_independence.json + e16b_classholdout.json
Exhaustive pairing coverage (Table 3) results/comorbidity_exhaustive_means.json
Self-mixing, healthy-partner controls, λ sweep results/e14_e17_selfmix.json
Degree- and weight-preserving graph null results/e19_graph_null.json
Blinded edge-level review package results/e5_blind_edge_package.xlsx / .json

Data sources

All analyses use publicly available GEO datasets: GSE42861, GSE179325, GSE111223, GSE113725, GSE128235, GSE44132, GSE198904, GSE201287.

Citation

@preprint{xiong2026morbidmap,
  title={Prescribing Without a Disease Diagnosis? Direct Intervention Ranking
         from a Health State-Representation Map for the Multimorbidity Challenge},
  author={Xiong, Jianghui},
  year={2026},
  note={Preprint. Code and frozen artifacts:
        https://github.com/DeepoMe/SteeraMed-MorbiMap}
}

Links

License

MIT (code) / CC BY 4.0 (data and documentation)

Contact

Jianghui Xiong — jianghui@deepome.com


健康状态表征地图能否直接排序候选药物——不需要疾病标签?

MorbiMap 是 SteeraMed 框架的候选排序组件。 它将健康状态表征地图(分子谱的模块加权表征)与冻结的药物-模块关联表连接,用固定评分程序排序候选药物——评分函数不需要疾病标签输入。

研究设计一览

Study Design

四个 DNA 甲基化队列 + 两个疾病基因签名 → 模块权重 → 冻结药物-模块表 → 固定评分 → 三层评测。

一份列表能否覆盖两组疾病标签?

Dual-Label Coverage

合成配对谱分析测试单个 top-20 列表能否覆盖两组疾病标签。抑郁-帕金森混合平均保留双基线;纯抑郁端点已达双覆盖。

核心发现

  • 高血压基因签名在 top 20 中恢复 6–7 个降压药;删除 30 个直接靶基因后保留 6 个
  • 抑郁与帕金森的高恢复与健康对照共享——由健康参照差分检出,药物排序/置换检查无法单独发现
  • 抑郁-帕金森配对中 32% 同时达到双基线;纯抑郁端点也达到双覆盖
  • 度数-权重保持的图空模型复现了重叠-覆盖关联(ρ_null = 0.85 vs 观测 0.90)

仓库状态

版本 1(预印本)。 当前提供结果-文件索引、代表性图表与版本声明。 分析代码、冻结候选池、阳性集文件、药物-模块表、审计链与复现脚本将在**版本 2(v2)**中发布。

数据来源

所有分析使用公开 GEO 数据集: GSE42861, GSE179325, GSE111223, GSE113725, GSE128235, GSE44132, GSE198904, GSE201287.

许可

MIT(代码)/ CC BY 4.0(数据与文档)

联系方式

熊江辉 — jianghui@deepome.com

DeepoMe · SteeraMed

About

MorbiMap: prescribing without a disease diagnosis — direct intervention ranking from a health state-representation map for the multimorbidity challenge. Companion to SteeraMed-RootMap. Paper: preprint forthcoming.

Topics

Resources

Stars

0 stars

Watchers

0 watching

Forks

Releases

Packages

Contributors